Stay updated on RC48-ADC in HER2+ Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the completed Phase II RC48-ADC study is displayed, including its participant criteria, study locations, treatment plan, and measured outcomes. The record also identifies the sponsor and investigator and notes that no results are posted.
    Difference
    45%
    Check dated 2026-11-10T19:23:26.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer's site revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T19:43:57.000Z thumbnail image
  3. Check
    23 days ago
    Change Detected
    Summary
    A banner was added announcing an NIH website transition and related terminology guidance, and the displayed site revision changed from v3.7.1 to v3.7.2. The page itself remains a 403 Forbidden error.
    Difference
    1%
    Check dated 2026-10-20T19:56:25.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier was updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:24:19.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page displays a 403 Forbidden message with basic navigation, replacing the usual study details and related links.
    Difference
    17%
    Check dated 2026-09-22T23:15:24.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now displayed on the page, replacing the prior Revision: v3.6.6 and indicating an updated page version. The update is an administrative version change and does not modify the study details presented.
    Difference
    0.1%
    Check dated 2026-09-15T22:05:57.000Z thumbnail image

Stay in the know with updates to RC48-ADC in HER2+ Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Urothelial Cancer Clinical Trial page.